Jeffrey L Greenwald1. 1. Boston University School of Medicine, Boston, Massachusetts, USA. Jeffrey.Greenwald@bmc.org
Abstract
BACKGROUND: The Centers for Disease Control and Prevention recommends routinely offering HIV testing to inpatients at hospitals with an HIV seroprevalence rate of greater than 1% or an AIDS diagnosis rate of greater than 1.0 per 1000 discharges. This recommendation has not been widely adopted, perhaps because of one of several barriers: the cost of implementing a counseling and testing program; the logistics of HIV counseling and testing on a hospital ward particularly with respect to privacy; concern about the follow-up of HIV test results necessitating patients to return after discharge; and the cultural mindset of screening as an outpatient modality complicated by the fear of raising the possibility of HIV testing and therefore eliciting a negative reaction from a patient who has not requested it. PURPOSE: This article focuses on these barriers and some possible solutions, emphasizing the role of FDA-approved rapid HIV tests, which may decrease follow-up issues for HIV testing programs. It also considers hospitalists, given their frontline status and ability to coordinate the multidisciplinary services and system-wide approach required to implement such a program, as leaders in this area. (c) 2006 Society of Hospital Medicine.
BACKGROUND: The Centers for Disease Control and Prevention recommends routinely offering HIV testing to inpatients at hospitals with an HIV seroprevalence rate of greater than 1% or an AIDS diagnosis rate of greater than 1.0 per 1000 discharges. This recommendation has not been widely adopted, perhaps because of one of several barriers: the cost of implementing a counseling and testing program; the logistics of HIV counseling and testing on a hospital ward particularly with respect to privacy; concern about the follow-up of HIV test results necessitating patients to return after discharge; and the cultural mindset of screening as an outpatient modality complicated by the fear of raising the possibility of HIV testing and therefore eliciting a negative reaction from a patient who has not requested it. PURPOSE: This article focuses on these barriers and some possible solutions, emphasizing the role of FDA-approved rapid HIV tests, which may decrease follow-up issues for HIV testing programs. It also considers hospitalists, given their frontline status and ability to coordinate the multidisciplinary services and system-wide approach required to implement such a program, as leaders in this area. (c) 2006 Society of Hospital Medicine.
Authors: Andrew C Voetsch; James D Heffelfinger; Juliet Yonek; Pragna Patel; Steven F Ethridge; Gretchen W Torres; Margaret A Lampe; Bernard M Branson Journal: Public Health Rep Date: 2012 Sep-Oct Impact factor: 2.792
Authors: Supriya D Mehta; Jonathan Hall; Jeffrey L Greenwald; Kevin Cranston; Paul R Skolnik Journal: Public Health Rep Date: 2008 Sep-Oct Impact factor: 2.792
Authors: Saeed Ahmed; Monica Schwarz; Robert J Flick; Chris A Rees; Mwelura Harawa; Katie Simon; Jeff A Robison; Peter N Kazembe; Maria H Kim Journal: Trop Med Int Health Date: 2016-02-29 Impact factor: 2.622